JPH02502376A - アリール‐及びアリールオキシ‐置換ｔ‐アルキレンアミン、その製法及びその製薬学的使用 - Google Patents

アリール‐及びアリールオキシ‐置換ｔ‐アルキレンアミン、その製法及びその製薬学的使用

Info

Publication number
JPH02502376A
JPH02502376A JP63501802A JP50180288A JPH02502376A JP H02502376 A JPH02502376 A JP H02502376A JP 63501802 A JP63501802 A JP 63501802A JP 50180288 A JP50180288 A JP 50180288A JP H02502376 A JPH02502376 A JP H02502376A
Authority
JP
Japan
Prior art keywords
formula
formulas
tables
methyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63501802A
Other languages
English (en)
Japanese (ja)
Inventor
アルブレヒト，ルードルフ
シエルコプフ，クラウス
レーマン，マンフレート
シュレーダー，ゲルトルート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPH02502376A publication Critical patent/JPH02502376A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
JP63501802A 1987-02-25 1988-02-23 アリール‐及びアリールオキシ‐置換ｔ‐アルキレンアミン、その製法及びその製薬学的使用 Pending JPH02502376A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873706585 DE3706585A1 (de) 1987-02-25 1987-02-25 Aryl- und aryloxy-substituierte tert.-alkylenamine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE3706585.8 1987-02-25

Publications (1)

Publication Number Publication Date
JPH02502376A true JPH02502376A (ja) 1990-08-02

Family

ID=6322048

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63501802A Pending JPH02502376A (ja) 1987-02-25 1988-02-23 アリール‐及びアリールオキシ‐置換ｔ‐アルキレンアミン、その製法及びその製薬学的使用

Country Status (4)

Country Link
EP (1) EP0346367A1 (fr)
JP (1) JPH02502376A (fr)
DE (1) DE3706585A1 (fr)
WO (1) WO1988006580A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004107323A (ja) * 2002-07-26 2004-04-08 Nippon Nohyaku Co Ltd 新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法
JPWO2005030720A1 (ja) * 2003-09-25 2007-11-15 塩野義製薬株式会社 Ｎｍｄａ受容体拮抗作用を有するピペリジン誘導体

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0637303A1 (fr) * 1992-04-24 1995-02-08 Smithkline Beecham Plc N-aryloxy(thio)alkyl-azacycloalcanes utiles en tant qu'antagonistes des canaux calciques
CA2152394A1 (fr) * 1992-12-22 1994-07-07 Ronald Joseph King Derives de la piperidine, antagonistes du canal calcique
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
AU2003252259A1 (en) * 2002-07-26 2004-02-16 Nihon Nohyaku Co., Ltd. Novel haloalkylsulfonanilide derivatives, herbicides and usage thereof
JP2009126785A (ja) * 2007-11-19 2009-06-11 Mitsubishi Gas Chem Co Inc ２−ヨード−３，４−ジメトキシベンゾニトリルの製造方法
JP2009126784A (ja) * 2007-11-19 2009-06-11 Mitsubishi Gas Chem Co Inc ２−ヨード−３，４−ジメトキシベンゾニトリルの製造方法。

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317538A (en) * 1965-10-22 1967-05-02 American Home Prod 4, 4'-diamino-butyrophenones
DE1618010A1 (de) * 1967-06-15 1970-11-05 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Aminoketonen
GB1262965A (en) * 1969-03-21 1972-02-09 Ferrosan As Butyrophenones
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
US4353900A (en) * 1981-10-19 1982-10-12 Syntex (U.S.A.) Inc. 9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones
US4613598A (en) * 1984-03-13 1986-09-23 Mitsubishi Chemical Industries Limited Piperazine derivatives and their acid addition salts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004107323A (ja) * 2002-07-26 2004-04-08 Nippon Nohyaku Co Ltd 新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法
JPWO2005030720A1 (ja) * 2003-09-25 2007-11-15 塩野義製薬株式会社 Ｎｍｄａ受容体拮抗作用を有するピペリジン誘導体

Also Published As

Publication number Publication date
WO1988006580A1 (fr) 1988-09-07
EP0346367A1 (fr) 1989-12-20
DE3706585A1 (de) 1988-09-08

Similar Documents

Publication Publication Date Title
ES2210524T3 (es) Derivados de chalcona y medicamentos que los contienen.
TW498067B (en) 4-hydroxy-piperidine derivatives
JPS61260063A (ja) フエニルアルカノ−ル誘導体
HU184966B (en) Process for producing phenyl-piperazine derivatives of anti-agression activity
NO126014B (fr)
TW200804341A (en) Amido compounds and their use as pharmaceuticals
BRPI0712631A2 (pt) "compostos, processo para a preparação de um composto, composição farmacêutica, uso de um composto e combinações"
BRPI0612957B1 (pt) composto, processos de preparação de compostos, composição farmacêutica e uso de um composto
LU86768A1 (fr) Derives de dichloroaniline
JPS6215546B2 (fr)
JPS58159484A (ja) 新規なピペラジン誘導体およびその製造方法
CA1306261C (fr) 1,4-dihydropyridines, leur procede de preparation et leur application comme medicaments
JPS6012350B2 (ja) 新規アリ−ルピペリジン誘導体の製造方法
JPH02502376A (ja) アリール‐及びアリールオキシ‐置換ｔ‐アルキレンアミン、その製法及びその製薬学的使用
IL44301A (en) 1-Aryloxy-2-Hydroxy-3-Alkylenylamino-propanes and their salts, their manufacture and pharmaceutical preparations containing them
JP2000086603A (ja) 桂皮酸アミド誘導体および３―フェニルプロピオン酸アミド誘導体
JPS5838263A (ja) ピリダジン誘導体
US9018213B2 (en) Alicyclic[c] benzopyrone derivatives and uses thereof
JPS62267250A (ja) 抗不整脈剤
WO2000035873A1 (fr) Procede de preparation de maleate de paroxetine
CN104945415B (zh) 7H‑苯并异噁唑并[7,6‑e][1,3]噁嗪类衍生物及应用
JPH05132453A (ja) 新規アミノフエノール誘導体及びその医薬組成物
JPWO2002030896A1 (ja) ２，２−ジフェニルブタンアミド誘導体及びこれを含有する医薬
JPS61210071A (ja) 抗高血圧性ジヒドロピリジン誘導体
NO169835B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive katecholkarboksylderivater